IMMUNOTHERAPY OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCCa) USING INTERLEUKIN-2 (IL-2) BASED THERAPY ADMINISTERED EITHER ALONE OR WITH IN VIVO PRIMED OR CD8+ SELECTED TUMOR INFILTRATING LYMPHOCYTES (TIL)
Year: 1993
Type: article
Source: Journal of Immunotherapy
Institution: University of California, Los Angeles
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2044512220
